Utilization of Intravenous Lidocaine Infusion for the Treatment of Refractory Chronic Pain
| Author | Janell Tully | en |
| Author | Jai Won Jung | en |
| Author | Anjana Patel | en |
| Author | Alyson Tukan | en |
| Author | Sameer Kandula | en |
| Author | Allen Doan | en |
| Author | Farnad Imani | en |
| Author | Giustino Varrassi | en |
| Author | Elyse M. Cornett | en |
| Author | Alan David Kaye | en |
| Author | Omar Viswanath | en |
| Author | Ivan Urits | en |
| Orcid | Farnad Imani [0000-0003-0814-0772] | en |
| Orcid | Giustino Varrassi [0000-0002-3822-2923] | en |
| Orcid | Elyse M. Cornett [0000-0001-7961-3931] | en |
| Orcid | Alan David Kaye [0000-0003-2464-0187] | en |
| Orcid | Omar Viswanath [0000-0002-6124-7037] | en |
| Orcid | Ivan Urits [0000-0002-3652-6085] | en |
| Issued Date | 2020-12-31 | en |
| Abstract | Context: Chronic pain accounts for one of the most common reasons patients seek medical care. The financial burden of chronic pain on health care is seen by direct financial cost and resource utilization. Many risk factors may contribute to chronic pain, but there is no definite risk. Managing chronic pain is a balance between maximally alleviating symptoms by utilizing a therapeutic regimen that is safe for long-term use. Currently, non-opioid analgesics, NSAIDs, and opioids are some of the medical treatment options, but these have numerous adverse effects and may not be the best option for long-term use. However, Lidocaine can achieve both central and peripheral analgesic effects with relatively few side effects, which may be an ideal compound for managing chronic pain. Evidence Acquisition: This is a Narrative Review. Results: Infusion of lidocaine (2-(diethylamino)-N-(2,6-dimethylphenyl)acetamide), an amino-amide compound, is emerging as a promising option to fill the therapeutic void for treatment of chronic pain. Numerous studies have outlined dosing protocols for lidocaine infusion for the management of perioperative pain, outlined below. While there are slight variations in these different protocols, they all center around a similar dosing regimen to administer a bolus to reach a rapid steady state, followed by infusion for up to 72 hours to maintain the therapeutic analgesic effects. Conclusions: Lidocaine may be a promising pharmacologic solution with a low side effect profile that provides central and peripheral analgesia. Even though the multifaceted mechanism is not entirely understood yet, lidocaine may be a promising novel remedy in treating chronic pain in various conditions. | en |
| DOI | https://doi.org/10.5812/aapm.112290 | en |
| Keyword | Chronic Pain | en |
| Keyword | Lidocaine | en |
| Keyword | Headache | en |
| Keyword | Fibromyalgia | en |
| Keyword | CRPS | en |
| Keyword | Low Back Pain | en |
| Publisher | Brieflands | en |
| Title | Utilization of Intravenous Lidocaine Infusion for the Treatment of Refractory Chronic Pain | en |
| Type | Review Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- aapm-10-6-112290.pdf
- Size:
- 145.71 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF